Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biotechnology Companies in 2024
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.
  1. Arrowhead Pharmaceuticals

    World Rank (Jan-05-2024)
    3,718
    Market Cap (Jan-05-2024)
    3.710 Billion USD
    World Rank (Jul-30-2023)
    3,705
    Market Cap (Jul-30-2023)
    3.755 Billion USD
    World Rank (Dec-25-2022)
    3,059
    Market Cap (Dec-25-2022)
    4.359 Billion USD
    World Rank (Jan-07-2022)
    2,778
    Market Cap (Jan-07-2022)
    6.16 Billion USD
    Annual Revenue in USD
    243 Million USD
    Annual Operating Income in USD
    -178 Million USD
    Annual Net Income in USD
    -172 Million USD
    Annual Results for Period Ending
    Sep-2022 ending year
    Headquarters Country
    Company Profile

    Bio-pharmaceutical company with headquarters is in California, USA.

  2. Remegen Co. Ltd

    World Rank (Jan-05-2024)
    3,721
    Market Cap (Jan-05-2024)
    3.708 Billion USD
    World Rank (Jul-30-2023)
    3,105
    Market Cap (Jul-30-2023)
    4.744 Billion USD
    World Rank (Dec-25-2022)
    2,201
    Market Cap (Dec-25-2022)
    6.419 Billion USD
    World Rank (Jan-07-2022)
    3,945
    Market Cap (Jan-07-2022)
    3.94 Billion USD
    Annual Revenue in USD
    207 Million USD
    Annual Net Income in USD
    40 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    RemeGen Co., Ltd is a traditional Chinese medicine company committed to the discovery development and commercialization of innovative and differentiated biologic drugs of significant clinical value in the key therapeutic areas of autoimmune oncology and ophthalmic diseases. The headquarters is in China.
  3. Financiere de Tubize SA

    World Rank (Jan-05-2024)
    3,759
    Market Cap (Jan-05-2024)
    3.650 Billion USD
    World Rank (Jul-30-2023)
    3,917
    Market Cap (Jul-30-2023)
    3.484 Billion USD
    World Rank (Dec-25-2022)
    3,821
    Market Cap (Dec-25-2022)
    3.304 Billion USD
    World Rank (Jan-07-2022)
    3,552
    Market Cap (Jan-07-2022)
    4.51 Billion USD
    Annual Revenue in USD
    421 Million USD
    Annual Net Income in USD
    419 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Financiere De Tubize is a Pharmaceutical company. The headquarters is in Belgium.

  4. Celltrion Pharm Inc.

    World Rank (Jan-05-2024)
    3,791
    Market Cap (Jan-05-2024)
    3.621 Billion USD
    World Rank (Jul-30-2023)
    5,151
    Market Cap (Jul-30-2023)
    2.366 Billion USD
    World Rank (Dec-25-2022)
    5,609
    Market Cap (Dec-25-2022)
    1.902 Billion USD
    Headquarters Country
    Company Profile

    Biotechnology sector company with headquarters in South Korea.

  5. Syngene International

    World Rank (Jan-05-2024)
    3,883
    Market Cap (Jan-05-2024)
    3.503 Billion USD
    World Rank (Jul-30-2023)
    3,508
    Market Cap (Jul-30-2023)
    4.030 Billion USD
    World Rank (Dec-25-2022)
    4,331
    Market Cap (Dec-25-2022)
    2.788 Billion USD
    World Rank (Jan-07-2022)
    4,440
    Market Cap (Jan-07-2022)
    3.39 Billion USD
    Annual Revenue in USD
    388 Million USD
    Annual Operating Income in USD
    74 Million USD
    Annual Net Income in USD
    56 Million USD
    Annual Results for Period Ending
    Mar-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Syngene International is an integrated research, development and manufacturing organisation providing scientific services company. It is offering services in a wide range of industrial sectors, including pharmaceutical, biotechnology, nutrition, animal health, consumer goods and speciality chemical companies. The company annual revenue is 255.4 million USD and 6,148 employees as on 2020. The headquarters is in India.
  6. Chinook Therapeutics Inc.

    World Rank (Jan-05-2024)
    3,888
    Market Cap (Jan-05-2024)
    3.500 Billion USD
    World Rank (Jul-30-2023)
    4,787
    Market Cap (Jul-30-2023)
    2.609 Billion USD
    World Rank (Dec-25-2022)
    6,021
    Market Cap (Dec-25-2022)
    1.699 Billion USD
    World Rank (Jan-07-2022)
    10,625
    Market Cap (Jan-07-2022)
    0.81 Billion USD
    Annual Revenue in USD
    6 Million USD
    Annual Operating Income in USD
    -173 Million USD
    Annual Net Income in USD
    -187 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Chinook Therapeutics, Inc. is a Clinical Stage Biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases. The headquarters is in USA.

    Novartis acquired Chinook Therapeutics Inc. for 3.5 billion USD in 2023.

    Facts About Company

    Chinook Therapeutics, Inc. Annual Total Revenue for year ending Dec-2022 was 6 million USD and and Net loss for year ending Dec-2022 was -187 million USD.

    Chinook Therapeutics, Inc. Annual Total Revenue for year ending Dec-2021 was 51 million USD and and Net loss for year ending Dec-2021 was -102 million USD.

    As on 2022, Chinook Therapeutics, Inc. has 214 employees.

  7. Laboratorios Farmaceuticos Rovi

    World Rank (Jan-05-2024)
    3,904
    Market Cap (Jan-05-2024)
    3.477 Billion USD
    World Rank (Jul-30-2023)
    4,965
    Market Cap (Jul-30-2023)
    2.487 Billion USD
    World Rank (Dec-25-2022)
    5,494
    Market Cap (Dec-25-2022)
    1.975 Billion USD
    World Rank (Jan-07-2022)
    3,728
    Market Cap (Jan-07-2022)
    4.22 Billion USD
    Annual Revenue in USD
    715 Million USD
    Annual Net Income in USD
    169 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Laboratorios Farmaceuticos Rovi is a specialized pharmaceutical company engaged in the research, development, manufacture and marketing of pharmaceutical products. The company annual revenue is 419.9 million EUR, annual net income is 61 million EUR and total assets are 574.4 million EUR as on 2020. The headquarters is in Spain.
  8. Xenon Pharmaceuticals

    World Rank (Jan-05-2024)
    3,922
    Market Cap (Jan-05-2024)
    3.464 Billion USD
    World Rank (Jul-30-2023)
    5,199
    Market Cap (Jul-30-2023)
    2.331 Billion USD
    World Rank (Dec-25-2022)
    4,829
    Market Cap (Dec-25-2022)
    2.382 Billion USD
    World Rank (Jan-07-2022)
    7,271
    Market Cap (Jan-07-2022)
    1.57 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Net Income in USD
    -28 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Xenon Pharmaceuticals is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The headquarters is in Canada.
  9. MoonLake Immunotherapeutics

    World Rank (Jan-05-2024)
    3,968
    Market Cap (Jan-05-2024)
    3.404 Billion USD
    World Rank (Jul-30-2023)
    4,196
    Market Cap (Jul-30-2023)
    3.164 Billion USD
    World Rank (Dec-25-2022)
    14,035
    Market Cap (Dec-25-2022)
    0.390 Billion USD
    Headquarters Country
    Company Profile
    MOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.
  10. Biohaven Pharmaceutical Holding Company

    World Rank (Jan-05-2024)
    3,972
    Market Cap (Jan-05-2024)
    3.399 Billion USD
    World Rank (Jul-30-2023)
    7,470
    Market Cap (Jul-30-2023)
    1.300 Billion USD
    World Rank (Dec-25-2022)
    8,706
    Market Cap (Dec-25-2022)
    0.934 Billion USD
    World Rank (Jan-07-2022)
    2,147
    Market Cap (Jan-07-2022)
    8.44 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -567 Million USD
    Annual Net Income in USD
    -570 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Biohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.

Share

Ads